Industrieforum · Industrial Forum

Marinus J. Wiezer(St. Antonius Ziekenhuis), Sunny Dzik(Massachusetts General Hospital), M. Eckermann, S. Meijer, B. Wiedemann(University of Bonn), L Brethner, W. Geise, R. Langer, Ralf Kätzel, E. Bauermann, C. Meijer(Leiden University Medical Center), B. Voigt, D. Wiebecke, H.A. Henrich, Michael Karl(Vita-Salute San Raffaele University), Behrouz Mansouri Taleghani(University of Bern), Alexander P. J. Houdijk(Medisch Centrum Alkmaar), J. Mädler, R. Großmann(University of Würzburg), R.H.J. Beelen, Paul A.M. van Leeuwen(Erasmus MC Cancer Institute), R. P. Bleichrodt, P.M. Trenchard, R. Dixon, H. A. Prins(Jeroen Bosch Ziekenhuis), Alexander Karl, H. Keuper, F Reinhardt, Ineke Linde

Transfusion Medicine and Hemotherapy

January 1, 1998

10.1159/000053436

Cited by 1

Related Papers

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

|The Lancet. Gastroenterology & hepatology|2019|326

Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria

|Journal of Clinical Oncology|2011|209

The ladies trial: laparoscopic peritoneal lavage or resection for purulent peritonitisA and Hartmann's procedure or resection with primary anastomosis for purulent or faecal peritonitisB in perforated diverticulitis (NTR2037)

|BMC Surgery|2010|128

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

|BMC Cancer|2019|111

Costs of complications after colorectal cancer surgery in the Netherlands: Building the business case for hospitals

|European Journal of Surgical Oncology|2015|103